| Sanofi-Aventis (Suisse) SA - Thyrogen, poudre pour solution injectable |
| 57687 | | 01 | | Thyrogen | | poudre pour solution injectable | | H01AB01 | | Thyrotropin Alfa | | 09.02.2007 | | |
|
| Composition |
| Praeparatio cryodesiccata: thyrotropinum alfa 0.9 mg, mannitolum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, pro vitro corresp. natrium 1.19 mg. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | poudre pour solution injectable | | | | | | | | Active Agent | Dose |
|---|
| Thyrotropin Alfa | 0.9 mg |
| | BAG: Active Agent | Dose |
|---|
| Thyrotropin Alfa | 0.9 mg |
| | | | Inactive agents |
|---|
| Disodium Phosphate Heptahydrate | | Mannitol | | Sodium Chloride | | Sodium Dihydrogenophosphate Monohydrate |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 2 Durchstechflasche(n) | 910.20 | 1006.30 | A | SL | No |
|
